BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18853582)

  • 21. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock?
    Routsi C; Giamarellos-Bourboulis EJ; Antonopoulou A; Kollias S; Siasiakou S; Koronaios A; Zakynthinos S; Armaganidis A; Giamarellou H; Roussos C
    Clin Exp Immunol; 2005 Oct; 142(1):62-7. PubMed ID: 16178857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.
    de Werra I; Jaccard C; Corradin SB; Chioléro R; Yersin B; Gallati H; Assicot M; Bohuon C; Baumgartner JD; Glauser MP; Heumann D
    Crit Care Med; 1997 Apr; 25(4):607-13. PubMed ID: 9142024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression.
    Dimopoulou I; Pelekanou A; Mavrou I; Savva A; Tzanela M; Kotsaki A; Kardara M; Orfanos SE; Kotanidou A; Giamarellos-Bourboulis EJ
    J Crit Care; 2012 Jun; 27(3):294-300. PubMed ID: 21855288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: a prospective observational cohort study.
    Lin MT; Wei YF; Ku SC; Lin CA; Ho CC; Yu CJ
    J Formos Med Assoc; 2010 Nov; 109(11):800-9. PubMed ID: 21126652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K
    J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study.
    Kwofie L; Rapoport BL; Fickl H; Meyer PW; Rheeder P; Hlope H; Anderson R; Tintinger GR
    Ann Hematol; 2012 Apr; 91(4):605-11. PubMed ID: 21976106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock.
    Heper Y; Akalin EH; Mistik R; Akgöz S; Töre O; Göral G; Oral B; Budak F; Helvaci S
    Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):481-91. PubMed ID: 16896829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection.
    Adib-Conquy M; Monchi M; Goulenok C; Laurent I; Thuong M; Cavaillon JM; Adrie C
    Shock; 2007 Oct; 28(4):406-10. PubMed ID: 17558349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.
    Clec'h C; Fosse JP; Karoubi P; Vincent F; Chouahi I; Hamza L; Cupa M; Cohen Y
    Crit Care Med; 2006 Jan; 34(1):102-7. PubMed ID: 16374163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
    Lin CH; Hsieh SC; Keng LT; Lee HS; Chang HT; Liao WY; Ho CC; Yu CJ
    PLoS One; 2016; 11(4):e0153938. PubMed ID: 27096761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Values for serum procalcitonin, C-reactive protein, and soluble triggering receptor expressed on myeloid cells-1 in predicting survival of patients with early-onset stroke-associated pneumonia.
    Xie J; Zhang XH; Zhu WY
    Genet Mol Res; 2015 May; 14(2):4716-23. PubMed ID: 25966246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis.
    Cabioglu N; Bilgic S; Deniz G; Aktas E; Seyhun Y; Turna A; Gunay K; Esen F
    Arch Surg; 2002 Sep; 137(9):1037-43; discussion 1043. PubMed ID: 12215155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study.
    Arízaga-Ballesteros V; Alcorta-García MR; Lázaro-Martínez LC; Amézquita-Gómez JM; Alanís-Cajero JM; Villela L; Castorena-Torres F; Lara-Díaz VJ
    Int J Infect Dis; 2015 Jan; 30():27-32. PubMed ID: 25461656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The predictor value of peripheral blood procalcitonin levels in the evaluation of prognosis of patients with septic shock].
    Chen W; Li LJ; Gu XY; Wang SZ; Zhao L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Aug; 24(8):470-3. PubMed ID: 22871405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia.
    Müller B; Gencay MM; Gibot S; Stolz D; Hunziker L; Tamm M; Christ-Crain M
    Crit Care Med; 2007 Mar; 35(3):990-1. PubMed ID: 17421114
    [No Abstract]   [Full Text] [Related]  

  • 36. Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study.
    Ruiz-Rodríguez JC; Caballero J; Ruiz-Sanmartin A; Ribas VJ; Pérez M; Bóveda JL; Rello J
    Med Intensiva; 2012 Oct; 36(7):475-80. PubMed ID: 22257436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis.
    Giamarellos-Bourboulis EJ; Zakynthinos S; Baziaka F; Papadomichelakis E; Virtzili S; Koutoukas P; Armaganidis A; Giamarellou H; Roussos C
    Intensive Care Med; 2006 Feb; 32(2):237-243. PubMed ID: 16450102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease.
    Shu CC; Lee LN; Wu MF; Lee CH; Wang JT; Wang JY; Yu CJ;
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1415-20. PubMed ID: 22283904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock.
    Pauly D; Hamed S; Behnes M; Lepiorz D; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
    J Crit Care; 2016 Feb; 31(1):68-75. PubMed ID: 26489483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of soluble triggering receptor expressed in myeloid cells-1 in distinguishing SIRS, sepsis, and septic shock in the pediatric intensive care unit.
    Duramaz BB; Ankay N; Yesilbas O; Kihtir HS; Yozgat CY; Petmezci MT; Gedikbasi A; Sevketoglu E
    Arch Pediatr; 2021 Oct; 28(7):567-572. PubMed ID: 34393025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.